The DexCom story
What drives DexCom, what its price assumes and what could change the story, written from its own filings.
- International growth leads. In the quarter to June 2026, international revenue grew 19% while the larger U.S. business grew 11%.
- Margins widen. DexCom's GAAP operating margin reached 24.3% in the quarter to June 2026, compared with 18.4% in the quarter to June 2025.
- Broader access takes shape. The quarter to June 2026 brought positive CONNECT trial results for people with type 2 diabetes not using insulin and the start of a redesigned Stelo app launch.
